Amedisys earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

UnitedHealth Group CEO Andrew Witty has stepped down unexpectedly and company veteran Stephen Hemsley is returning to the top ...

Stephen Hemsley ran UnitedHealth Group for more than a decade. It's a different company after four years with Andrew Witty in ...

Andrew Witty, chief executive of UnitedHealth Group, has stepped down from his role for “personal reasons,” the company announced Tuesday. UnitedHealth also withdrew its financial forecast for 2025, ...

There’s new leadership at the nation’s largest healthcare company, but the transition brings a familiar face back to the helm after a tumultuous year for UnitedHealth Group. Ten notes: 1. UnitedHealth ...

The company brought back Chairman and former CEO Stephen Hemsley for the top role, saying Andrew Witty has resigned “for ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. Amedisys delivers ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q4 2024 in the United States.

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.